Mikael Dolsten
President R&D at Pfizer; Director at Agilent Technologies; Director at Rocket Pharmaceuticals. Based in Santa Clara, California.
- Rank
- 8839th of 14,644
- Companies held
- 3
- Largest holding
- PFE, 89.9% of total
- Latest SEC filing
- Sep 4, 2026
What the $9.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Pfizer PFE Common Stock | Directly | 321,729 | $27.54 | $8.9M | 89.3% | Form 4, Feb 28, 2024 |
| Agilent Technologies A Common Stock | Directly | 4,924 | $175.34 | $863K | 8.7% | Form 4, Sep 4, 2026 |
| Rocket Pharmaceuticals RCKT Common Stock | Directly | 67,082 | $2.11 | $142K | 1.4% | Form 4, Jun 18, 2026 |
| Pfizer PFE Common Stock | Through Rule 16b-3 Plan | 1,981 | $27.54 | $55K | 0.5% | Form 4, Feb 28, 2024 |
Share counts are the amounts Mikael Dolsten reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8836 | Kevin C. Talley EVP and CAO, Advanced Drainage Systems. Hilliard, OH | $9.9M |
| 8837 | Robert M. VanHimbergen VP Corporate Controller, Johnson Controls International. Indianapolis, IN | $9.9M |
| 8838 | Michael Madsen Former President & CEO, AEROF, Honeywell International. Charlotte, NC | $9.9M |
| 8839 | Mikael Dolsten President R&D, Pfizer. Santa Clara, CA | $9.9M |
| 8840 | Roderick A. Palmore Director, Cboe Global Markets. Chicago, IL | $9.9M |
| 8841 | Thomas D. Campion Chairman of Board of Directors, Zumiez. Lynnwood, WA | $9.9M |
| 8842 | David G Nord Director, Ryder System. Charlotte, NC | $9.9M |
Other Pfizer insiders
All PFE insiders- Frank A. Damelio$15.3MExecutive Vice President. #3598 overall
- Albert Bourla$12.0MChairman & CEO. #7660 overall
- Sally Susman$4.7MExecutive Vice President. #14273 overall
- Ronald E. Blaylock$2.0MDirector. #6740 overall
- David M. Denton$1.0MChief Financial Officer & EVP. #5077 overall
- Cyrus Taraporevala$275KDirector. #5742 overall
Questions
How much stock does Mikael Dolsten own?
Mikael Dolsten holds $9,919,834 in listed stock based on SEC filings and current prices, mostly Pfizer (PFE). That ranks 8839th on the Stock Rich List.
Is this Mikael Dolsten's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mikael Dolsten last buy or sell stock?
The most recent open-market trade on file is a sale of 634 A shares on Sep 4, 2026 at $151.38.